Logo image of CYPH

CYPHERPUNK TECHNOLOGIES INC (CYPH) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:CYPH - US52187K2006 - Common Stock

1.1 USD
-0.2 (-15.38%)
Last: 12/22/2025, 8:00:00 PM
1.1 USD
0 (0%)
Pre-Market: 12/23/2025, 7:01:17 AM
Fundamental Rating

2

Overall CYPH gets a fundamental rating of 2 out of 10. We evaluated CYPH against 530 industry peers in the Biotechnology industry. The financial health of CYPH is average, but there are quite some concerns on its profitability. CYPH does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year CYPH has reported negative net income.
In the past year CYPH has reported a negative cash flow from operations.
In the past 5 years CYPH always reported negative net income.
CYPH had a negative operating cash flow in each of the past 5 years.
CYPH Yearly Net Income VS EBIT VS OCF VS FCFCYPH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M

1.2 Ratios

CYPH's Return On Assets of -445.76% is on the low side compared to the rest of the industry. CYPH is outperformed by 96.23% of its industry peers.
The Return On Equity of CYPH (-1885.42%) is worse than 83.02% of its industry peers.
Industry RankSector Rank
ROA -445.76%
ROE -1885.42%
ROIC N/A
ROA(3y)-109.13%
ROA(5y)-86.19%
ROE(3y)-140.51%
ROE(5y)-107.95%
ROIC(3y)N/A
ROIC(5y)N/A
CYPH Yearly ROA, ROE, ROICCYPH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K

1.3 Margins

CYPH does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CYPH Yearly Profit, Operating, Gross MarginsCYPH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K -2K -2.5K

More info and screens

5

2. Health

2.1 Basic Checks

CYPH has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CYPH has more shares outstanding
There is no outstanding debt for CYPH. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
CYPH Yearly Shares OutstandingCYPH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CYPH Yearly Total Debt VS Total AssetsCYPH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of -71.03, we must say that CYPH is in the distress zone and has some risk of bankruptcy.
CYPH has a Altman-Z score of -71.03. This is amonst the worse of the industry: CYPH underperforms 95.09% of its industry peers.
CYPH has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -71.03
ROIC/WACCN/A
WACCN/A
CYPH Yearly LT Debt VS Equity VS FCFCYPH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M

2.3 Liquidity

A Current Ratio of 1.21 indicates that CYPH should not have too much problems paying its short term obligations.
CYPH has a worse Current ratio (1.21) than 86.04% of its industry peers.
A Quick Ratio of 1.21 indicates that CYPH should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.21, CYPH is not doing good in the industry: 85.09% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 1.21
Quick Ratio 1.21
CYPH Yearly Current Assets VS Current LiabilitesCYPH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

CYPH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.79%, which is quite impressive.
EPS 1Y (TTM)36.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.82%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, CYPH will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.23% on average per year.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y38.47%
EPS Next 2Y30.62%
EPS Next 3Y19.23%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CYPH Yearly Revenue VS EstimatesCYPH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 500K 1M 1.5M
CYPH Yearly EPS VS EstimatesCYPH Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -10 -20 -30

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CYPH. In the last year negative earnings were reported.
Also next year CYPH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CYPH Price Earnings VS Forward Price EarningsCYPH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CYPH Per share dataCYPH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.2 -0.4 -0.6 -0.8 -1

4.3 Compensation for Growth

A more expensive valuation may be justified as CYPH's earnings are expected to grow with 19.23% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y30.62%
EPS Next 3Y19.23%

More info and screens

0

5. Dividend

5.1 Amount

CYPH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

CYPHERPUNK TECHNOLOGIES INC

NASDAQ:CYPH (12/22/2025, 8:00:00 PM)

Premarket: 1.1 0 (0%)

1.1

-0.2 (-15.38%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)03-24 2026-03-24/amc
Inst Owners13.99%
Inst Owner ChangeN/A
Ins Owners10.99%
Ins Owner Change0%
Market Cap62.32M
Revenue(TTM)N/A
Net Income(TTM)-50.81M
Analysts43.33
Price TargetN/A
Short Float %7.93%
Short Ratio0.12
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)16.05%
Min EPS beat(2)-35.23%
Max EPS beat(2)67.32%
EPS beat(4)2
Avg EPS beat(4)8.97%
Min EPS beat(4)-35.23%
Max EPS beat(4)67.32%
EPS beat(8)5
Avg EPS beat(8)7.5%
EPS beat(12)8
Avg EPS beat(12)-11.28%
EPS beat(16)10
Avg EPS beat(16)-10.76%
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 23.12
P/tB 23.12
EV/EBITDA N/A
EPS(TTM)-1.22
EYN/A
EPS(NY)-0.54
Fwd EYN/A
FCF(TTM)-0.93
FCFYN/A
OCF(TTM)-0.93
OCFYN/A
SpS0
BVpS0.05
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -445.76%
ROE -1885.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-109.13%
ROA(5y)-86.19%
ROE(3y)-140.51%
ROE(5y)-107.95%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.21
Quick Ratio 1.21
Altman-Z -71.03
F-Score3
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.82%
EPS Next Y38.47%
EPS Next 2Y30.62%
EPS Next 3Y19.23%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y30.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-13.81%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.81%
OCF growth 3YN/A
OCF growth 5YN/A

CYPHERPUNK TECHNOLOGIES INC / CYPH FAQ

What is the fundamental rating for CYPH stock?

ChartMill assigns a fundamental rating of 2 / 10 to CYPH.


What is the valuation status of CYPHERPUNK TECHNOLOGIES INC (CYPH) stock?

ChartMill assigns a valuation rating of 0 / 10 to CYPHERPUNK TECHNOLOGIES INC (CYPH). This can be considered as Overvalued.


How profitable is CYPHERPUNK TECHNOLOGIES INC (CYPH) stock?

CYPHERPUNK TECHNOLOGIES INC (CYPH) has a profitability rating of 0 / 10.


How financially healthy is CYPHERPUNK TECHNOLOGIES INC?

The financial health rating of CYPHERPUNK TECHNOLOGIES INC (CYPH) is 5 / 10.